WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998049319) HUMAN LYSOPHOSPHOLIPASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/049319    International Application No.:    PCT/US1998/008782
Publication Date: 05.11.1998 International Filing Date: 29.04.1998
Chapter 2 Demand Filed:    12.11.1998    
IPC:
A61K 38/00 (2006.01), C12N 9/18 (2006.01)
Applicants: INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive, Palo Alto, CA 94304 (US) (AM, AT, AU, AZ, BE, BF, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CY, DE, DK, ES, FI, FR, GA, GB, GH, GM, GN, GR, IE, IL, IT, JP, KE, KG, KZ, LS, LU, MC, MD, ML, MR, MW, MX, NE, NL, NO, NZ, PT, RU, SD, SE, SG, SN, SZ, TD, TG, TJ, TM, UG, ZW only).
HILLMAN, Jennifer, L. [US/US]; (US) (For US Only).
SHAH, Purvi [IN/US]; (US) (For US Only).
MURRY, Lynn, E. [US/US]; (US) (For US Only)
Inventors: HILLMAN, Jennifer, L.; (US).
SHAH, Purvi; (US).
MURRY, Lynn, E.; (US)
Agent: BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc., 3174 Porter Drive, Palo Alto, CA 94304 (US)
Priority Data:
08/844,120 29.04.1997 US
09/022,940 12.02.1998 US
Title (EN) HUMAN LYSOPHOSPHOLIPASE
(FR) LYSOPHOSPHOLIPASE HUMAINE
Abstract: front page image
(EN)The invention provides a human lysophospholipase (NHLP) and polynucleotides which identify and encode NHLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of NHLP.
(FR)Lysophospholipase humaine (NHLP) et polynucléotides qui identifient et codent ladite NHLP. La présente invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes, ainsi que des méthodes de traitement ou de prophylaxie de troubles associés à l'expression de la NHLP.
Designated States: AT, AU, BR, CA, CH, CN, DE, DK, ES, FI, GB, IL, JP, KZ, MX, NO, NZ, RU, SE, SG, US.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)